EMD-27617

Helical reconstruction
7.85 Å
EMD-27617 Deposition: 13/07/2022
Map released: 07/09/2022
Last modified: 17/01/2024
Overview 3D View Sample Experiment Validation Volume Browser Additional data Links
Overview 3D View Sample Experiment Validation Volume Browser Additional data Links

EMD-27617

Helical reconstruction of A92E HIV capsid in complex with CPSF6 construct (filtered by local resolution)

EMD-27617

Helical reconstruction
7.85 Å
EMD-27617 Deposition: 13/07/2022
Map released: 07/09/2022
Last modified: 17/01/2024
Overview 3D View Sample Experiment Validation Volume Browser Additional data Links
Sample Organism: Human immunodeficiency virus 1
Sample: HIV Capsid Protein Hexamer

Deposition Authors: Iqbal N , Asturias F , Kvaratskhelia M
Prion-like low complexity regions enable avid virus-host interactions during HIV-1 infection.
PUBMED: 36202818
DOI: doi:10.1038/s41467-022-33662-6
ISSN: 2041-1723
Abstract:
Cellular proteins CPSF6, NUP153 and SEC24C play crucial roles in HIV-1 infection. While weak interactions of short phenylalanine-glycine (FG) containing peptides with isolated capsid hexamers have been characterized, how these cellular factors functionally engage with biologically relevant mature HIV-1 capsid lattices is unknown. Here we show that prion-like low complexity regions (LCRs) enable avid CPSF6, NUP153 and SEC24C binding to capsid lattices. Structural studies revealed that multivalent CPSF6 assembly is mediated by LCR-LCR interactions, which are templated by binding of CPSF6 FG peptides to a subset of hydrophobic capsid pockets positioned along adjoining hexamers. In infected cells, avid CPSF6 LCR-mediated binding to HIV-1 cores is essential for functional virus-host interactions. The investigational drug lenacapavir accesses unoccupied hydrophobic pockets in the complex to potently impair HIV-1 inside the nucleus without displacing the tightly bound cellular cofactor from virus cores. These results establish previously undescribed mechanisms of virus-host interactions and antiviral action.